Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-016360

Options or other derivatives

  • Director acquired 796,154 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Waksal Harlan · Director

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-11-17 Grant or award : show line 1 in the form Common Stock Option +96,154 $0.26 2020-11-17 96,154 360,112 D
2010-11-17 Grant or award : show line 2 in the form Common Stock Option +200,000 $0.26 2020-11-17 200,000 560,112 D
2010-11-17 Grant or award : show line 3 in the form Common Stock Option +500,000 $0.26 2020-11-17 500,000 1,060,112 D
Loading xslF345X03/edgar.xml…